- Acumen Powered by Robins Kaplan LLP™
- Affirmative Recovery
- American Indian Law and Policy
- Antitrust and Trade Regulation
- Appellate Advocacy and Guidance
- Business Litigation
- Civil Rights and Police Misconduct
- Class Action Litigation
- Commercial/Project Finance and Real Estate
- Corporate Governance and Special Situations
- Corporate Restructuring and Bankruptcy
- Domestic and International Arbitration
- Health Care Litigation
- Insurance and Catastrophic Loss
- Intellectual Property and Technology Litigation
- Mass Tort Attorneys
- Medical Malpractice Attorneys
- Personal Injury Attorneys
- Telecommunications Litigation and Arbitration
- Wealth Planning, Administration, and Disputes
-
July 27, 2021Robins Kaplan Secures $19.5M Settlement for Indirect Buyers in Interior Molded Doors Antitrust Litigation
-
July 21, 2021Benchmark Litigation Names Patrick Arenz and Aaron Fahrenkrog to its 40 & Under Hot List in 2021
-
July 20, 2021Five Robins Kaplan Firm Members Recognized by Minnesota Lawyer
-
August 5, 2021Domesticating an Out of State Judgment in The State of Florida
-
August 6, 2021Mastering the Deposition: 30(b)(6) Deposition Strategies and Updates 2021
-
August 19, 2021Annual Robins Kaplan MAJ Reception
-
July 15, 2021Biotechnology & Trade Secret Protection
-
July 6, 2021'Abuse of dominance': Was this what Congress originally intended for Section 2?
-
Summer 2021Family Feud: A Cautionary Tale of the Costs, Risks, and Uncertainty of Minority-Shareholder Litigation
-
July 28, 2021Financial Daily Dose 7.28.2021 | Top Story: Big Tech Reports Massive Q2 Results
-
July 27, 2021Financial Daily Dose 7.27.2021 | Top Story: Insurance Giants Aon and Willis Towers Watson Call Off Planned Merger After DOJ Pushback
-
July 26, 2021Financial Daily Dose 7.26.2021 | Top Story: Top Crypto Exchanges Limit Leverage to Curb Risk
Find additional firm contact information for press inquiries.
Read our attorneys' take on the latest news and trends in the legal and business industries.
FDA Should Follow FTC For Influencer Health Post Rules
August 11, 2020
Social media influencers have become the latest source of health information. This is especially true right now, in the middle of the ongoing and rapidly evolving COVID-19 pandemic. Influencers are being tapped to spread the word about public health campaigns, wellness goods and services, prescription drugs, and medical devices. Because these promotions and unsolicited advertisements are rampant, they deserve the close attention of not only consumers, but of our government.
The articles on our website include some of the publications and papers authored by our attorneys, both before and after they joined our firm. The content of these articles should not be taken as legal advice. The views and opinions expressed in this article are those of the author(s) and do not necessarily reflect the views or official position of Robins Kaplan LLP.
Reena Jain, Carly Kessler - Law360
READ FULL ARTICLE Related Professionals
Carly Kessler
Associate
Related Publications
October 1, 2020
How The Music Industry Can Weather COVID-19
Carly Kessler, Lauren Birkenstock - Law360
Fall 2020
Don’t Stop the Music: The Intersection Between Insurance and The Music Industry in the Era of COVID-19
Carly Kessler, Lauren Birkenstock - REAL TALK: The Robins Kaplan Business Law Update Fall 2020
Fall 2020
Interview with Uzma Saghir, Senior Corporate Counsel at Liberty Mutual
Manleen Singh - REAL TALK: The Robins Kaplan Business Law Update Fall 2020
June 16, 2020
Collateralized Loan Obligations: Emerging Litigation Risks
Stacey Slaughter, Austin Hurt, Vincent Licata
June 8, 2020
Proposed COVID-19 Legislation Thrusts Contract Clause’s Original Purpose Into Spotlight
Robert F. Callahan, Jr.
Related News
December 7, 2020
October 19, 2020
May 6, 2020
Back to Top
Any information that you send us in an e-mail message should not be confidential or otherwise privileged information. Sending us an e-mail message will not make you a client of Robins Kaplan LLP. We do not accept representation until we have had an opportunity to evaluate your matter, including but not limited to an ethical evaluation of whether we are in a conflict position to represent you. Accordingly, the information you provide to us in an e-mail should not be information for which you would have an expectation of confidentiality.
If you are interested in having us represent you, you should call us so we can determine whether the matter is one for which we are willing or able to accept professional responsibility. We will not make this determination by e-mail communication. The telephone numbers and addresses for our offices are listed on this page. We reserve the right to decline any representation. We may be required to decline representation if it would create a conflict of interest with our other clients.
By accepting these terms, you are confirming that you have read and understood this important notice.
If you are interested in having us represent you, you should call us so we can determine whether the matter is one for which we are willing or able to accept professional responsibility. We will not make this determination by e-mail communication. The telephone numbers and addresses for our offices are listed on this page. We reserve the right to decline any representation. We may be required to decline representation if it would create a conflict of interest with our other clients.
By accepting these terms, you are confirming that you have read and understood this important notice.